Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls

NCT06808516 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Arginine Vasopressin Deficiency
Central Diabetes Insipidus
Oxytocin Deficiency

Interventions

DRUG: Oxytocin nasal spray
DRUG: Placebo

Sponsor

University Hospital, Basel, Switzerland